IKS Health Reports Robust Q2 FY26 Performance with 22% Revenue Growth and 35% EBITDA Margins
Inventurus Knowledge Solutions Limited (IKS Health) reported impressive Q2 FY26 results. Revenue increased 22% YoY to ₹781.00 crores, EBITDA grew 43% to ₹272.00 crores, and PAT rose 60% to ₹181.00 crores. The company's EBITDA margin reached 35%, reflecting operational efficiency. IKS Health secured new clients, including AdventHealth and Revere Health, while accelerating its AI-native platform transformation. The company is focusing on about 50 customers with potential for $50 million each in Annual Contract Value over the next five years.

*this image is generated using AI for illustrative purposes only.
Inventurus Knowledge Solutions Limited (IKS Health) has reported strong financial results for the second quarter of fiscal year 2026, demonstrating significant growth across key metrics and expanding its client base.
Financial Highlights
IKS Health's Q2 FY26 performance showcases impressive year-on-year growth:
| Metric | Q2 FY26 | YoY Growth |
|---|---|---|
| Revenue | ₹781.00 crores | 22% |
| EBITDA | ₹272.00 crores | 43% |
| PAT | ₹181.00 crores | 60% |
| EBITDA Margin | 35.00% | - |
| EPS | ₹10.80 | - |
The company's revenue growth of 22% year-on-year outpaces the market's expansion rate of 12%, indicating market share gains. The EBITDA margin of 35% reflects the company's operational efficiency and successful implementation of AI-driven solutions.
Operational Performance
IKS Health's operational metrics also show positive trends:
- Operating cash flow: ₹291.00 crores
- Free cash flow: ₹225.00 crores
- Top 10 customers now comprise 45% of revenue
- Average tenure of top 10 customers: 6 years
Strategic Developments
The company has made significant strides in its strategic initiatives:
AI Implementation: IKS Health has accelerated its AI-native platform transformation, contributing to margin expansion ahead of schedule.
AQuity Delivery Model Transformation: The company has successfully transformed the AQuity delivery model, enhancing operational efficiency.
New Client Acquisitions: IKS Health secured notable new clients, including AdventHealth, Revere Health, Jackson Clinic, and a leading cardiology group.
Platform Integration: The company has integrated two of its features with Epic Electronic Health Record software, a crucial step for expanding its presence in large health systems.
Market Position and Future Outlook
Sachin Gupta, Founder and CEO of IKS Health, emphasized the company's strong position in the $260 billion Total Addressable Market (TAM), of which only $34 billion has been outsourced. The company is focusing on about 50 customers with potential for $50 million each in Annual Contract Value (ACV) over the next five years.
IKS Health's strategy involves:
- Transforming its platform to be AI-native and agentic
- Expanding cross-sell opportunities within the AQuity customer base
- Driving platform adoption in single-specialty and multi-specialty market segments
- Enhancing integration with key healthcare IT systems like Epic
The company maintains a positive outlook on its ability to continue growing faster than the market expansion rate, leveraging its comprehensive platform approach and focus on customer outcomes.
As IKS Health continues to execute its strategic initiatives and capitalize on the growing demand for healthcare technology solutions, it appears well-positioned for sustained growth in the coming quarters.
Historical Stock Returns for Inventurus Knowledge Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.05% | +6.41% | +7.71% | +13.28% | -14.96% | -14.96% |










































